Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Precancerous neoplastic cells can move through the pancreatic ductal system.

Makohon-Moore AP, Matsukuma K, Zhang M, Reiter JG, Gerold JM, Jiao Y, Sikkema L, Attiyeh MA, Yachida S, Sandone C, Hruban RH, Klimstra DS, Papadopoulos N, Nowak MA, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA.

Nature. 2018 Sep;561(7722):201-205. doi: 10.1038/s41586-018-0481-8. Epub 2018 Sep 3.

2.

Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.

Furukawa T, Fujisaki R, Yoshida Y, Kanai N, Sunamura M, Abe T, Takeda K, Matsuno S, Horii A.

Mod Pathol. 2005 Aug;18(8):1034-42.

3.
4.

Where and when does pancreatic carcinoma start?

Lüttges J, Hahn S, Klöppel G.

Med Klin (Munich). 2004 Apr 15;99(4):191-5.

PMID:
15085289
5.

[Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].

Ott C, Heinmöller E, Gaumann A, Schölmerich J, Klebl F.

Med Klin (Munich). 2007 Feb 15;102(2):127-35. Review. German.

PMID:
17323019
6.

Precancerous conditions of pancreatic carcinoma.

Lüttges J, Klöppel G.

J Hepatobiliary Pancreat Surg. 2000;7(6):568-74. Review.

PMID:
11180888
7.

NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.

Chen NM, Singh G, Koenig A, Liou GY, Storz P, Zhang JS, Regul L, Nagarajan S, Kühnemuth B, Johnsen SA, Hebrok M, Siveke J, Billadeau DD, Ellenrieder V, Hessmann E.

Gastroenterology. 2015 May;148(5):1024-1034.e9. doi: 10.1053/j.gastro.2015.01.033. Epub 2015 Jan 23.

8.

Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.

Singh M, Maitra A.

Pancreatology. 2007;7(1):9-19. Epub 2007 Apr 18. Review.

PMID:
17449961
9.

[New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].

Esposito I, Konukiewitz B, Schlitter AM, Klöppel G.

Pathologe. 2012 Nov;33 Suppl 2:189-93. doi: 10.1007/s00292-012-1673-x. Review. German.

PMID:
23011021
10.

Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.

Biankin AV, Kench JG, Dijkman FP, Biankin SA, Henshall SM.

Pathology. 2003 Feb;35(1):14-24. Review.

PMID:
12701679
11.
12.

Clinical importance of precursor lesions in the pancreas.

Hruban RH, Takaori K, Canto M, Fishman EK, Campbell K, Brune K, Kern SE, Goggins M.

J Hepatobiliary Pancreat Surg. 2007;14(3):255-63. Epub 2007 May 29. Review.

PMID:
17520200
13.

Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing.

Iacobuzio-Donahue CA, Velculescu VE, Wolfgang CL, Hruban RH.

Clin Cancer Res. 2012 Aug 15;18(16):4257-65. doi: 10.1158/1078-0432.CCR-12-0315. Review.

14.

A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.

Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, Chadwick D, Hafezi-Bakhtiari S, Dick JE, Heisler L, Hollingsworth MA, Ibrahimov E, Jang GH, Johns J, Jorgensen LG, Law C, Ludkovski O, Lungu I, Ng K, Pasternack D, Petersen GM, Shlush LI, Timms L, Tsao MS, Wilson JM, Yung CK, Zogopoulos G, Bartlett JM, Alexandrov LB, Real FX, Cleary SP, Roehrl MH, McPherson JD, Stein LD, Hudson TJ, Campbell PJ, Gallinger S.

Nature. 2016 Oct 20;538(7625):378-382. doi: 10.1038/nature19823. Epub 2016 Oct 12. Erratum in: Nature. 2017 Feb 2;542(7639):124.

15.

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I.

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

PMID:
21984419
16.
17.

Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.

Fendrich V, Jendryschek F, Beeck S, Albers M, Lauth M, Esni F, Heeger K, Dengler J, Slater EP, Holler JPN, Baier A, Bartsch DK, Waldmann J.

Oncogene. 2018 Apr;37(14):1845-1856. doi: 10.1038/s41388-017-0100-4. Epub 2018 Jan 25.

PMID:
29367759
18.

[Precursors to pancreatic cancer].

Søreide K, Immervoll H, Molven A.

Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8. Review. Norwegian.

19.

Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.

Sawai Y, Kodama Y, Shimizu T, Ota Y, Maruno T, Eso Y, Kurita A, Shiokawa M, Tsuji Y, Uza N, Matsumoto Y, Masui T, Uemoto S, Marusawa H, Chiba T.

Cancer Res. 2015 Aug 15;75(16):3292-301. doi: 10.1158/0008-5472.CAN-14-3028. Epub 2015 Jun 25.

20.

Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Koorstra JB, Feldmann G, Habbe N, Maitra A.

Langenbecks Arch Surg. 2008 Jul;393(4):561-70. doi: 10.1007/s00423-008-0282-x. Epub 2008 Feb 19. Review.

Supplemental Content

Support Center